Biobanking Market worth $152.75 billion by 2030, growing at a CAGR of 11.71% - Exclusive Report by 360iResearch

The "Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Biobanking Market to grow from USD 70.33 billion in 2023 to USD 152.75 billion by 2030, at a CAGR of 11.71%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/biobanking?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Biobanking involves the collection, storage, management, processing, and distribution of biological samples from humans and animals for research and clinical purposes. It serves various sectors, including pharmaceuticals, biotechnology companies, academic institutions, and healthcare organizations. Applications include drug discovery, diagnostics development, personalized medicine research, and biomarker identification. Rising chronic disease prevalence such as cancer requires early detection and treatment methodologies and necessitates efficient sample storage, increasing deployment of biobanking. Moreover, increasing focus on precision medicine and government investments in national biobank networks are propelling the growth of the market. Furthermore, ensuring sample quality control and maintaining standardized protocols in collecting, processing, and storing samples are major concerns, as inconsistencies can lead to unreliable research outcomes. Data privacy is another pressing issue, with an increasing number of biobanks handling sensitive patient information. Also, leveraging emerging technologies including robotics automation systems for sample handling, enhancing data security through digitalization using blockchain technology, and implementing environmentally sustainable practices including energy-efficient storage units create lucrative opportunities for market growth.

In the Americas, the US biobanking industry plays a pivotal role in advancing biomedical research through initiatives such as the National Institutes of Health's All of Us Research Program. Furthermore, investments from state governments are driving the establishment of new biobanks. The EU biobanking market is bolstered by collaborations among various countries under initiatives such as Biobanking and BioMolecular resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC). Additionally, funding programs, including Horizon 2020, have facilitated advancements in personalized medicine. In Africa, initiatives including H3Africa have promoted the development of biorepositories across the continent to support genomics research on African populations. The APAC region is experiencing rapid growth due to government policies that allocate funds for medical innovation and precision medicine. India hosts several regional biobanks focusing on disease-specific applications such as cancer research.

Market Segmentation & Coverage:

This research report categorizes the Biobanking Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables, Equipment & Instruments, Services, and Software. The Software is projected to witness significant market share during forecast period.

Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids. The Blood Products is projected to witness significant market share during forecast period.

Based on Storage Type, market is studied across Automated and Manual. The Automated is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine. The Life Science Research is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceutical & Biotechnology. The Pharmaceutical & Biotechnology is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.35% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/biobanking?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Biobanking Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Biobanking Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L'AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Biobanking Market, by Product
7. Biobanking Market, by Sample Type
8. Biobanking Market, by Storage Type
9. Biobanking Market, by Application
10. Biobanking Market, by End-User
11. Americas Biobanking Market
12. Asia-Pacific Biobanking Market
13. Europe, Middle East & Africa Biobanking Market
14. Competitive Landscape
15. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Biobanking Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Biobanking Market?
3. What is the competitive strategic window for opportunities in the Biobanking Market?
4. What are the technology trends and regulatory frameworks in the Biobanking Market?
5. What is the market share of the leading vendors in the Biobanking Market?
6. What modes and strategic moves are considered suitable for entering the Biobanking Market?

Read More @ https://www.360iresearch.com/library/intelligence/biobanking?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.